Although it is well known that sphingolipids are very important in tumor biology, it is unknown whether expression of the acid sphingomyelinase in malignant tumors, in particular in PDAC has an impact on the prognosis and long-term survival of patients. This evidence concerns the gene SMPD1 and cancer.